Source externe
ScienceDaily – Health & Medicine
Scientists trick cancer cells into making the drugs that kill them
Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells themselves. Early laboratory experiments suggest the technique could selectively attack cancer…
le 4 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
Scientists discover that some “unhealthy” diets can boost cancer immunotherapy in mice
In a surprising discovery, scientists found that certain diets associated with obesity can make cancer immunotherapy more effective in mice, challenging traditional assumptions about diet and cancer treatment. The findings suggest that the secret may lie in how food interacts…
le 2 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
Even moderate drinking linked to cancer and early death, major study finds
A major new study challenges the idea that moderate drinking is safe, finding that even relatively small amounts of alcohol increase the risk of cancer, heart disease, and premature death. Researchers found no overall health benefits from drinking and warn that consuming more…
le 2 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
Scientists use sound waves to deliver a new attack on deadly brain cancer
Scientists at the University of Virginia have developed a promising new strategy to fight glioblastoma, one of the deadliest and most difficult-to-treat forms of brain cancer. Their experimental approach combines focused ultrasound, tiny nanoparticles, and genetic molecules…
le 1 nov. 2026· OncologieLire chez la source
Source externe
ScienceDaily – Health & Medicine
Why some “lower-risk” childhood cancers turn deadly
Scientists have uncovered hidden aggressive cancer cells in children whose tumors were previously considered lower risk, revealing why some cases of rhabdomyosarcoma become unexpectedly deadly. The discovery could help doctors identify dangerous tumors earlier and develop…
le 30 oct. 2026· OncologieLire chez la source
Source externe
FDA – Press Releases
FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery
The U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that may allow some patients with locally advanced rectal cancer to avoid common treatments that can have a lasting impact on their daily life.
le 19 oct. 2026· OncologieLire chez la source
Source externe
FDA – Press Releases
FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
le 14 oct. 2026· OncologieLire chez la source
← Plus récentes
Page 5 sur 5
